Kalorama: Top Companies Dominate Cardiac Defibrillator Market
NEW YORK, May 22, 2015 /PRNewswire/ -- The leading companies in the cardiac defibrillator segment of the $13 billion global cardiac rhythm management device market dominate their competition, according to Kalorama Information. Kalorama found that Medtronic, St. Jude Medical, Boston Scientific and Asahi Kasei (with ZOLL Medical) command 80% of this market segment. The healthcare market research publisher's report, Cardiac Rhythm Management Device Markets, uses 2015 as a base year, providing forecasts for each year through 2020. The market is evaluated via a combination of disease prevalence trends, population trends, device innovations, federal and industry standards and regulations.
Cardiac Rhythm Management Device Markets can be found at Kalorama Information: http://www.kaloramainformation.com/redirect.asp?progid=87484&productid=8911435.
"The cardiac defibrillator market is highly competitive and varies in participation by device segment," said Bruce Carlson, publisher of Kalorama. "The implantable segment, for instance, is dominated by a handful of companies and these providers maintain their hold on market penetration."
Cardiac defibrillators are electrical devices that deliver therapeutic levels of energy to the heart muscle for the treatment of ventricular defibrillation, cardiac dysrhythmias and pulseless ventricular tachycardia. Devices can be implanted in the body, external, or transvenous. The goal of the technology is to reestablish the normal rhythm of the heartbeat.
The implantable defibrillator device segment has gained wide acceptance over the past decade. Within this segment are advanced versions of the technology, including cardiac resynchronization therapy defibrillators (CRT-D). The external defibrillator device market consists of professional/manual defibrillators and automatic external defibrillators, commonly referred to as AEDs. The implantable transvenous cardioverter-defibrillator segment consists of devices implantable inside the body, able to perform both cardioversion, defibrillation and pacing of the heart.
In many markets, the top companies maintain their market edge through patented innovation. The cardiac defibrillator segment is no exception. Medtronic is listed in over 7,186 patents that describe medical devices, tissue-related systems, instrumentation, user interfaces, sensors, therapy systems, implantable devices, delivery devices, and monitoring technologies. There are 898 patents in the U.S. database under the St. Jude Medical name – for cardiovascular devices, implantables, sutures, fixation systems, ablation technology, an implantable system for measuring mechanical dyssynchronicity of the heart and catheters. Boston Scientific holds over 3,894 patents; recent technologies described in these patents include medical devices in neurostimulation, cardiology and other surgery. Asahi Kasei (with ZOLL Medical) has 105 patents in the U.S. patent database; recent patented technologies include systems for energy delivery, medical monitoring and a defibrillator with a light sensor. These market leaders use their patents to assert a level of control over their intellectual property and in so doing also help to maintain their market share.
Cardiac Rhythm Management Device Markets breaks down the cardiac rhythm device market into its segments, with market sizing and forecasts to 2020:
- Sales of Cardiac Defibrillator by Type (External, Implantable)
- Sales of External Defibrillators by Product Type, (AEDs, Professional/Manual Defibrillators)
- Sales of Implantable Cardiac Defibrillators by Product Type, 2015 (Standard ICD, CRT-D)
- Sales of Cardiac Pacemaker by External and Implantable Types
- Sales of Implantable Cardiac Pacemakers by Product Type (Standard ICP, CRT-P)
As cardiovascular disease is an international problem and the focus of major world healthcare systems, the report also provides overall rhythm management device market size and forecasts (2010-2020) for each of the following countries: United States, Germany, UK, Italy, France, Spain, Brazil, China, Japan and Australia.
Primary sources for the report include telephone interviews and email correspondence with more than 100 key industry officials, consultants, health care providers, and government personnel on the topic of cardiac rhythm management. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report.
Cardiac Rhythm Management Device Markets can be found at Kalorama Information: http://www.kaloramainformation.com/redirect.asp?progid=87484&productid=8911435.
About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.
We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog at www.kaloramainformation.com.
Contact:
Bruce Carlson
(212) 807-2622
[email protected]
www.KaloramaInformation.com
Logo - http://photos.prnewswire.com/prnh/20140801/132634
SOURCE Kalorama Information
Share this article